Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BLPH Bellerophon Therapeutics

Watchlist
1.020
+0.004+0.39%
Close 12/02 16:00 ET
1.0200.0000.00%
Post Mkt Price 12/02 16:32 ET
High
1.030
Open
1.005
Turnover
2.43K
Low
1.005
Pre Close
1.016
Volume
2.39K
Market Cap
9.74M
P/E(TTM)
Loss
52wk High
3.720
Shares
9.55M
P/E(Static)
Loss
52wk Low
0.670
Float Cap
7.13M
Bid/Ask %
20.00%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
0.32
Historical Low
0.670
Dividend TTM
--
Div Yield TTM
--
P/B
1.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
2.46%
Avg Price
1.019
Lot Size
1
Float Cap
7.13M
Bid/Ask %
20.00%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
0.32
Historical Low
0.670
Dividend TTM
--
P/B
1.31
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
2.46%
Avg Price
1.019
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
CEO: Mr. Peter Fernandes
Market: NASDAQ
Listing Date: 02/13/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist